Mirum Pharmaceuticals, Inc.

Senior Product Manager, LIVMARLI Marketing

Mirum Pharmaceuticals, Inc.  •  $175k - $185k/yr  •  Foster City, CA (Hybrid)  •  9 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

MISSION

Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.

The Senior Product Manager, Patient Marketing for LIVMARLI, will play a critical support role to the Senior Marketing Director in the strategic and tactical execution of marketing initiatives to support the continued success of LIVMARLI. This individual will help plan, coordinate, and implement key brand activities across digital, field, patient, and healthcare provider channels.

This role is ideal for a motivated, resourceful, and digitally-savvy professional who is eager to learn, take ownership of meaningful projects, and grow within a high-performing, mission-driven commercial team.

JOB FUNCTIONS/RESPONSIBILITIES

Brand & Marketing Support

  • Partner with the Senior Director, Marketing to execute the annual brand plans for LIVMARLI.
  • Assist in developing marketing materials (Patient/caregiver, digital, etc.) in alignment with strategic objectives and compliance standards.
  • Support execution of omnichannel marketing initiatives, including HCP and patient campaigns, digital content, CRM/email marketing, and social media.
  • Coordinate review and approval (MLR) processes, ensuring materials are accurate, timely, and compliant.
  • Support tactical execution of field force tools and branded and unbranded education initiatives.
  • Manage creative and digital agency partners, ensuring deliverables are high-quality, compliant, and on-time.
  • Support ongoing field team enablement through tools, resources, and internal communications.
  • Maintain awareness of emerging digital tools and rare disease engagement innovations.
  • Help maintain brand budgets and timelines.
  • Prepare summaries, presentations, and reports for leadership and brand review meetings.
  • Work closely with cross-functional partners (Medical Affairs, Market Access, Patient Services, Commercial Operations, and Field Teams) to ensure alignment and seamless execution.

Qualifications

Education & Experience

  • Bachelor’s degree in business, marketing, life sciences, or related field required
  • 3–6 years of experience in pharmaceutical marketing, product management, or commercial operations, ideally in rare disease.

Knowledge, Skills and Abilities:

  • Strong organizational, project management, and communication skills.
  • High attention to detail with ability to manage multiple priorities and deadlines.
  • Digital fluency – comfortable with CRM systems, analytics platforms, and digital campaign tools.
  • Analytical mindset – able to synthesize data and insights to inform decisions.

The salary range for this position is $175,000 to $185,000 USD. Compensation will be determined based on several factors including, but not limited to; skill set, years of experience, and the employee’s geographic location. Please note that the required compensation details listed in US role postings reflect the base salary only, and do not include bonus, equity, or benefits unless otherwise provided.

#LI-HYBRID

Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.

Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.

Mirum Pharmaceuticals, Inc.

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat), CHOLBAM® (cholic acid) capsules, and CTEXLI™ (chenodiol) tablets.

LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients 12 months of age and older; in Europe, it is approved for patients with PFIC three months of age and older. Mirum is also initiating the Phase 3 EXPAND study, a label expansion opportunity for LIVMARLI in additional settings of cholestatic pruritus. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms of liver disease. CTEXLI is FDA-approved for the treatment of cerebrotendinous xanthomatosis (CTX) in adults.

Mirum's late-stage pipeline includes two investigational treatments for several rare diseases. Volixibat, an IBAT inhibitor, is being evaluated in two potentially registrational studies including the Phase 2 VISTAS study for primary sclerosing cholangitis (PSC) and Phase 2b VANTAGE study for primary biliary cholangitis (PBC). Volixibat has been granted Breakthrough Therapy Designation for the treatment of cholestatic pruritus in patients with PBC. Mirum is also planning for a Phase 2 study evaluating MRM-3379, a PDE4D inhibitor for the treatment of Fragile X syndrome, a rare genetic neurocognitive disorder.

Industry
Chemicals & Materials
Company Size
201-500 employees
Headquarters
Foster City, CA
Year Founded
2018
Social Media